← FDA Drug Approvals (Drugs@FDA)

BUMETANIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: UPSHER SMITH LABS · Approved 2018-01-23

Drug application

FDA Application #
ANDA209916
Application type
Abbreviated New Drug Application (Generic)
Brand name
BUMETANIDE
Generic name
BUMETANIDE
Active ingredients
BUMETANIDE
Dosage form
TABLET
Route
ORAL
Marketing status
Prescription
Sponsor
UPSHER SMITH LABS
Manufacturer
Upsher-Smith Laboratories, LLC
First approval
2018-01-23

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown